All Stories

  1. STARLINER study, disease behaviour assessed by a wide range of parameters including patient-reported outcomes (PRO) results
  2. Effects of nintedanib in patients with IPF: subgroup analysis by Charlson Comorbidity Index (CCI)
  3. Pulmonary alveolar microlithiasis: no longer in the stone age
  4. Efficacy and safety of nintedanib in the elderly patient with IPF
  5. DANILDA – The First Danish National Interstitial Lung Disease Registry
  6. Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management
  7. Danish respiratory society position paper: palliative care in patients with chronic progressive non-malignant lung diseases